Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
LIPI and ECOG PS independently were able to estimate 90-day mortality, with LIPI also demonstrating prognostic validity for 30-day mortality and early progression.
Authors
- Paola Valeria Marchese (ORCID: https://orcid.org/0000-0002-1309-2819)
- Sebastiano Buti (ORCID: https://orcid.org/0000-0003-0876-0226)
- Francesco Gelsomino (ORCID: https://orcid.org/0000-0002-9204-1728)
- Giulia Mazzaschi (ORCID: https://orcid.org/0000-0003-4019-579X)
- Maria Abbondanza Pantaleo (ORCID: https://orcid.org/0000-0002-0177-6957)
- Andrea Ardizzoni (ORCID: https://orcid.org/0000-0003-2678-0714)
- Veronica Mollica (ORCID: https://orcid.org/0000-0002-5169-3631)
- Karim Rihawi (ORCID: https://orcid.org/0000-0002-3915-466X)
- Francesca Carosi
- Francesca Comito (ORCID: https://orcid.org/0000-0002-8591-0788)
- Valentina Favorito (ORCID: https://orcid.org/0009-0001-5282-260X)
- Andrea Marchetti (ORCID: https://orcid.org/0000-0001-7892-9619)
- Francesco Massari (ORCID: https://orcid.org/0000-0001-6476-6871)
- Fabiana Perrone (ORCID: https://orcid.org/0000-0001-8090-770X)
- Alessandro Leonetti (ORCID: https://orcid.org/0000-0001-5415-6703)
- Ambrogio Gagliano
- M. Peroni (ORCID: https://orcid.org/0009-0006-4306-7979)
- Alessandro Di Federico (ORCID: https://orcid.org/0000-0001-8877-4315)
- Barbara Melotti (ORCID: https://orcid.org/0000-0003-1041-391X)
- Francesca Sperandi (ORCID: https://orcid.org/0000-0002-1581-3456)
- Daria Maria Filippini (ORCID: https://orcid.org/0000-0003-3328-7282)
- Matteo Rosellini (ORCID: https://orcid.org/0000-0002-4920-9951)
- Andrea De Giglio (ORCID: https://orcid.org/0000-0002-0731-5721)
- Elisabetta Nobili
- Ilaria Ricciotti
- Marcello Tiseo
Institutions
- University of Parma (IT)
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1007/s00262-024-03836-w
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.70